Cargando…
The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK
INTRODUCTION: Due to the complexity of biologics and the inherent challenges for manufacturing, it is important to know the specific brand name and batch number of suspected biologics in adverse drug reaction (ADR) reports. OBJECTIVE: The aim of this study was to assess the extent to which biologics...
Autores principales: | Klein, Kevin, Hazell, Lorna, Stolk, Pieter, Shakir, Saad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048707/ https://www.ncbi.nlm.nih.gov/pubmed/31872358 http://dx.doi.org/10.1007/s40264-019-00891-6 |
Ejemplares similares
-
Challenges and Opportunities for the Traceability of (Biological) Medicinal Products
por: Klein, Kevin, et al.
Publicado: (2018) -
Pilot study of a manualised mental health awareness and stigma reduction intervention for Black faith communities in the UK: ON TRAC project
por: Codjoe, Louisa, et al.
Publicado: (2023) -
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?
por: Dhanda, Sandeep, et al.
Publicado: (2022) -
UK veterinary professionals’ perceptions and experiences of adverse drug reaction reporting
por: Davies, Heather, et al.
Publicado: (2022) -
Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports
por: Klein, Kevin, et al.
Publicado: (2015)